Latest1 information on COVID-19

Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based Contrast

Not Recruiting

Trial ID: NCT00230295

Age - 18 Years-N/A Condition - Head and Neck Cancers (H&N) Gender - All Accepting Healthy Volunteers - No

Purpose

To determine the ability of magnetic resonance lymphangiography using conventional gadolinium injected directly into the tumor site and PET scan in detecting microscopic nodal metastasis in patients with newly diagnosed H&N cancers

Official Title

Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based Contrast

Stanford Investigator(s)

Billy W Loo, Jr, MD PhD FASTRO FACR
Billy W Loo, Jr, MD PhD FASTRO FACR

Professor of Radiation Oncology (Radiation Therapy)

Quynh-Thu Le, MD
Quynh-Thu Le, MD

Katharine Dexter McCormick and Stanley McCormick Memorial Professor and Professor, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS)

Lei Xing

Eligibility


Inclusion Criteria:Patients with newly diagnosed squamous cell carcinomas of the H&N with
primary tumor sites that are accessible to direct contrast injections

View More
View Less

Intervention(s):

procedure: IMR LAG

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Bill Loo
6507367143

New Trial Alerts

Receive email alerts when trials open to patients.

©2022 Stanford Medicine